Related Experiment Video

Updated: May 17, 2026

Cortical Source Analysis of High-Density EEG Recordings in Children
09:32

Cortical Source Analysis of High-Density EEG Recordings in Children

Published on: June 30, 2014

Bera study in 150 children under five years age

K K Desarda1, A N Sangekar

  • 1K.E.M. Hospital, 411 011 Pune.

Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India
|November 3, 2012
PubMed

Insights

Brainstem Auditory Evoked Response (BAER) effectively diagnoses hearing impairments in children under five. Early detection via BAER enables timely intervention, crucial for speech and language development.

Area of Science:

  • Pediatric audiology
  • Neuroscience

Background:

  • Hearing impairments in children can be conductive or sensorineural.
  • Early detection is vital for speech and language development.
  • Brainstem Auditory Evoked Response (BAER) is a diagnostic tool.

Purpose of the Study:

  • To evaluate the utility of BAER in diagnosing hearing impairments in young children.
  • To correlate BAER findings with risk factors and developmental milestones.

Main Methods:

  • Study included 150 children under five years of age.
  • Case history profiles were recorded, including high-risk factors, adoption referrals, congenital malformations, and delayed speech.
  • Brainstem Auditory Evoked Response (BAER) testing was performed.

Main Results:

  • BAER proved effective in identifying hearing impairments.
  • Accurate hearing sensitivity assessment was achieved through BAER.
  • The study observed correlations between risk factors and hearing loss.

Conclusions:

  • BAER is a reliable tool for diagnosing hearing sensitivity in children.
  • Early diagnosis through BAER facilitates prompt rehabilitation.
  • Timely intervention supports optimal speech and language development.

More Related Videos

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools11:29

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools

Published on: June 20, 2020

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...